EC Number   |
Activating Compound |
Reference |
|---|
   3.4.25.1 | 19S regulatory particle |
- |
688337 |
| 3.4.25.1 | Blm10 protein |
- |
688337 |
| 3.4.25.1 | leupeptin |
0.05 mg/ml, activation to 125% of the original activity, peptidyl-glutamyl-peptide-hydrolyzing activity, hydrolysis of benzyloxycarbonyl-LLE-2-naphthylamide |
649428 |
| 3.4.25.1 | chymostatin |
0.05 mg/ml, activation to 170% of the original activity, peptidyl-glutamyl-peptide-hydrolyzing activity, hydrolysis of benzyloxycarbonyl-LLE-2-naphthylamide |
649428 |
| 3.4.25.1 | PA200 |
activator protein |
752830 |
| 3.4.25.1 | PA28 |
activator protein |
752830 |
| 3.4.25.1 | doxorubicin |
apoptosis inductor doxorubicin increases enzymatic activities, regulates subunit composition, and phosphorylation state of 26S proteasomes |
685994 |
| 3.4.25.1 | nuclear factor erythroid-derived 2-related factor 1 |
i.e. Nrf1, a transcription factor of the cap and collar basic leucine zipper family, but not the related Nrf2, is necessary for induced proteasome gene transcription in cancer cell lines, overview |
713032 |
| 3.4.25.1 | nuclear factor erythroid-derived 2-related factor 1 |
i.e. Nrf1, a transcription factor of the cap and collar basic leucine zipper family, but not the related Nrf2, is necessary for induced proteasome gene transcription in mouse embryonic fibroblasts, overview. Knockdown of Nrf1 in wild-type mouse embryonic fibroblasts abolishes MG132-mediated upregulation of RNA levels of PSM genes |
713032 |
| 3.4.25.1 | more |
immediate early gene-X-1 may essentially modulate signalling pathways related to 26S proteasome activity |
684965 |
